Lanboto
Latest round
- Series C
Last raised
- Aug 2024
Total raised
- $15M
Investors
- 6
About Lanboto
Established in 2015 and based in Nanjing, China, Lanboto is a pet innovative drug developer that provides veterinary, pet specialties, food and feed. The company has a 2,000 square meter drug research and development center, 34 patents, and 8 new veterinary drug certificates. Chengqiang Zhu, the founder of the company, graduated from Nanjing Agricultural University, majoring in molecular genetics, and established Dr. Warm, a cloud-based SaaS management platform for pet hospitals. The company cooperates with Tmall Supermarket, Jingdong Self-support, Huayuan and Diman, etc. The company has 7 veterinary GMP production lines, including eye drops, ear drops, topical ointments, tablets, oral solutions, non-chlorine disinfectants and topical insecticides. Its products are divided into two series, which include innovative pet drugs and generic drugs. Innovative pet drugs include compound glycyrrhizin tablets, compound amino acid injections, cefpodoxime tablets and fipronil solution. Generic drugs include compound mycophenolic ointment and fipronil drops. The company also provides online pet light consultation services and value-added services such as operations management empowerment. The company generates revenue by selling compound glycyrrhizic acid tablets, pyrochloranil drops and other pet medicines.
Who invested in Lanboto
6 investors across 3 rounds
See all investors in Lanboto
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lanboto
Who invested in Lanboto?
Lanboto has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lanboto raised?
Lanboto has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Lanboto last raise money?
Lanboto's most recent round on record is a Series C, in Aug 2024.
What does Lanboto do?
Established in 2015 and based in Nanjing, China, Lanboto is a pet innovative drug developer that provides veterinary, pet specialties, food and feed.
Where is Lanboto headquartered?
Lanboto is headquartered in Nanjing, China.
Which VCs invest in companies like Lanboto?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Lanboto's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Lanboto? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.